Cytodyn Inc (CYDY)

[Emergcy]

A very nice letter from a poster on Yahoo. Very straight to the point and very important and correct:
Dear Dr. Pourhassan,
As an investor in Cytodyn and a supporter of the company and the drug Leronlimab, I respectfully request that you revise the most recent press release. The headline states “...Expected Regulatory Filings...”, while in the body of the release it says “Management will update stockholders on the Company’s recent COVID-19 related filings.......”
From this press release, it is impossible to determine whether the filings in the US, Canada and the UK are “expected” as the headline states, or if they have already been filed, as is stated in the body of the PR.
This is an extremely important point that is left to interpretation by this release. It is exactly this type of laxity in corporate communications that gets continually exploited by short sellers who like to attack the stock price. As a loyal shareholder who is tired of having to defend a great company and a great drug due to miscommunication, I implore you to both revise this PR and to take more care in public communications of all types going forward. Thank you for your consideration.